The 12 closest competitors and alternatives to Dren Bio, Inc. among biopharmaceuticals companies — ranked by similarity to what Dren Bio, Inc. actually does, not by market-cap band.
Subscribe to see Dren Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dren Bio, Inc. is a biotechnology company headquartered in San Carlos, California, focused on developing powerful protein-engineering technologies.
Dren Bio, Inc. is a biopharmaceuticals company headquartered in United States. Its most recent funding round raised $25M in July 2024. Xcout tracks 14 named people at Dren Bio, Inc., including Amit Mehta (Chief Operating Officer and Chief Business Officer).
8 more named people on record for Dren Bio, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $25M | — | |
| Series B | $65M | 2 named | |
| Series A | $60M | 2 named | |
| SEC Form D filing | $25.5M | — | |
| SEC Form D filing | $5.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Dren Bio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biopharmaceuticals company
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company located in South San Francisco and Mountain View, California. The company focuses on oncology, leveraging its proprietary Pro-XTEN technology platform to engineer novel protein therapeutics.
Similar biopharmaceuticals company
Mendra is a venture-backed biotechnology research startup established in 2025 and headquartered in San Francisco, focused on accelerating the development and commercialization of rare disease therapies.
Similar biopharmaceuticals company
Dermira, Inc. is a biotechnology company focused on medical dermatology, with its main headquarters located in Menlo Park, California, United States.
Drug Discovery
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
Similar biopharmaceuticals company
Altay Therapeutics, Inc. is a biotechnology company founded in 2019 and headquartered in the San Francisco Bay Area, California. The company focuses on developing therapeutics within the biotechnology sector.
Drug Discovery
AllIn Bio is a drug discovery company headquartered in Woodside, California. The firm is developing a precision-immunology approach designed to treat the root cause of chronic inflammatory diseases.
Biology
Zafrens Inc. is a biotechnology and pharmaceutical company headquartered in San Diego, California, pioneering advanced life science tools and platforms.
Bio Tools
Drosera Bio is a privately held biotechnology company based in Cambridge, Massachusetts, that develops automation-native tools and material solutions to improve the efficiency and cost-effectiveness of bioprocesses.
Biotherapeutics
Headquartered in South San Francisco, California, Chimera Bioengineering is a privately held biotechnology company focused on developing advanced cellular engineering technologies for cancer therapies.
Medicines
Amber Bio is a privately held biotechnology company headquartered in San Francisco, California. The firm pioneers new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Dren Bio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →